3013 SCIENCE PARK, SAN DIEGO, CA
Unregistered Sales of Equity Securities
Announces Second Quarter 2025 Financial Results and Provides Business Update
Material disclosure
Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH
Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Other Events
Financial Results, Press Release
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
RW
S-3ASR
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
Delisting Amendment